RANWAN, India — In this north Indian village, workers recently dismantled stacks of burned and mildewed rice while flies swarmed nearby over spoiled wheat. Local residents said the rice crop had been sitting along the side of a highway for several years and was now being sent to a distillery to be turned into liquor. Just 180 miles to the south, in a slum on the outskirts of New Delhi, Leela...

-The Times of India With the development of cyclonic circulation over east central Arabian Sea on Tuesday, the southwest monsoon finally showed promise of progressing further into the country. In the next three days, the system which had so far stalled over coastal Karnataka and Tamil Nadu shortly after its onset on June 5 will become stronger over the west coast and Konkan.  "Under the influence of the cyclonic circulation, the southwest...

-The Hindu Aamir Khan's “Satyamev Jayate” has drawn sharp criticism from Indian Medical Association   Taking forward the debate on commercialisation of health, initiated by actor Aamir Khan in his television show “Satyamev Jayate” that drew sharp criticism from the Indian Medical Association (IMA), health activists have said distortions in medical practices, induced by unregulated commercialisation, have become systemic problems. In an open letter to the IMA, which has sought an apology from Mr....

-The Hindu Says it is well protected from tsunami or other natural disasters The Kudankulam Nuclear Power Project is well protected from tsunami or other natural disasters, the Centre submitted before the Madras High Court on Tuesday. It made the submission while the First Bench of Chief Justice M.Y. Eqbal and Justice T.S. Sivagnanam was hearing a batch of petitions seeking various reliefs, including a direction to the Union government and others to...

-The Economic Times   Pushed to the wall by an overly cautious drug regulator and an alarmist Indian government, clinical trial companies are looking at South East Asian countries to expand their business and escape the red tape of Indian authorities.  Clinical research companies (CROs), that were aspiring to become billion- dollar companies by 2010, had to rework their plans after a Parliamentary Standing Committee report questioned the allegedly unfair and unethical trials...